Hi Norman,
Priors is the summary of the data. You always loose something when you summarize the data. Sometime you have to use summaries because data are not available or when you want to support some parts of the model while allowing more flexibility to the other parts (for example, when you use adult priors + allometric scaling to support pediatric model). In other cases, it is better to use raw data without intermediate steps.

One (artificial but still valid) example is the nonlinear drug. At each dose level, you could be able to describe it by the linear model. But if you have data from several dose levels, you can develop the nonlinear model. Now assume that you have several (say 3) separate studies, each at one dose level. You will have 3 different linear models, each with different parameters, and with some uncertainty. I am not sure how to get a meaningful model out of these data summaries. Similarly, if you have different populations, or different distribution/representation of covariates, or different sampling scheme - I think it would be more beneficial to have all these diverse data in one set that to transfer information through the parameters.

Still, each particular case should be approached individually, I would not rule out any of the approaches (priors vs combining the data) without knowing details of the specific case.

Thanks
Leonid

--------------------------------------
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web:    www.quantpharm.com
e-mail: LGibiansky at quantpharm.com
tel:    (301) 767 5566



On 10/14/2011 10:45 PM, Norman Z wrote:
Hi Leonid,
Would you please explain why combine the data may be a better option
than using priors? I've met similar situations.
Thanks,
Norman

On Fri, Oct 14, 2011 at 5:01 PM, Leonid Gibiansky
<[email protected] <mailto:[email protected]>> wrote:

    Nele,

    Nonmem 7.2 has UNCONDITIONAL option in cov step that would compute
    SEs even for problems with error in minimization.

    Also, it is perfectly OK to have variance-covariance computed from
    bootstrap; some may even argue that it is better than use Nonmem cov
    matrix.

    And finally (just an opinion) I would rather combine the data than
    use priors.

    Thanks
    Leonid


    ------------------------------__--------
    Leonid Gibiansky, Ph.D.
    President, QuantPharm LLC
    web: www.quantpharm.com <http://www.quantpharm.com/>
    e-mail: LGibiansky at quantpharm.com <http://quantpharm.com/>
    tel: (301) 767 5566 <tel:%28301%29%20767%205566>




    On 10/13/2011 1:31 AM, Kaessner, Nele wrote:

        Dear all,

        I am currently in a planning phase for a PopPK evaluation for an
        upcoming study. I have already developed a PopPK model for this
        compound, and the idea would now be to fit the available model
        to the
        new data. One idea was to do this via the PRIOR functionality in
        NONMEM,
        so that I do not have to mix the old data into the new data set.
        So now
        I wanted to test the performance of this approach via
        simulations, and
        have the following problem:

        My previously developed final model did not converge successfully
        (terminated with rounding errors), so I do not have a covariance
        matrix
        of estimates to describe the uncertainty in the THETAs. However I
        obtained confidence intervals from a nonparametric bootstrap,
        and I was
        wondering if these results can somehow be used instead for the prior
        information.

        In some internal discussions we had the idea to just use all the
        parameter estimates from the performed 1000 bootstrap runs, and just
        calculate variance and covariance of THETAs from these.

        I would highly appreciate your comments on the validity of such an
        approach, or suggestions of other alternatives.

        Thanks and best regards

        Nele

        __________________________________________________________________

        Dr. Nele Kنكner


        PK/PD Sciences

        Modelling and Simulation (RDP/MS)

        *Nycomed: A Takeda Company*


        Nycomed GmbH

        Byk-Gulden-Str. 2

        D-78467 Konstanz, Germany

        Fon: (+49) 7531 / 84 - 4759
        <tel:%28%2B49%29%207531%20%2F%2084%20-%204759>

        Fax: (+49) 7531 / 84 - 94759
        <tel:%28%2B49%29%207531%20%2F%2084%20-%2094759>

        mailto: [email protected]
        <mailto:[email protected]>
        <mailto:nele.kaessner@nycomed.__com
        <mailto:[email protected]>>

        http://www.nycomed.com <http://www.nycomed.com/>
        <http://www.nycomed.com/>


        County Court: Freiburg, Commercial Register HRB 701257

        Chairman Supervisory Board: Charles Depasse (Speaker)

        Management Board: Gilbert Rademacher (Speaker),
        Konstantin von Alvensleben, Dr. Rainer Wiartalla



        ------------------------------__------------------------------__--------

        The content of this email and of any files transmitted may contain
        confidential, proprietary or legally privileged information and is
        intended solely for the use of the person/s or entity/ies to
        whom it is
        addressed. If you have received this email in error you have no
        permission whatsoever to use, copy, disclose or forward all or
        any of
        its contents. Please immediately notify the sender and
        thereafter delete
        this email and any attachments.

        ------------------------------__------------------------------__--------


Reply via email to